[1] World Health Organization. Global tuberculosis report 2016. http://www.who.int/tb/publications/global_report/en. [2017-02-01].
[2] Skeiky YA, Sadoff JC. Advances in tuberculosis vaccine strategies. Nat Rev Microbiol, 2006; 4, 469-76. doi:  10.1038/nrmicro1419
[3] World Health Organization. Guidelines on the management of latent tuberculosis infection. 2015. http://www.who.int/entity/tb/publications/latent-tuberculosis-infection/en/. [2017-2-1].
[4] Mack U, Migliori GB, Sester M, et al. TBNET. LTBI:latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J, 2009; 33, 956-73. http://www.cabdirect.org/abstracts/20093131996.html
[5] Gupta A, Kaul A, Tsolaki AG, et al. Mycobacterium tuberculosis:Immune evasion, latency and reactivation. Immunobiology, 2012; 217, 363-74. doi:  10.1016/j.imbio.2011.07.008
[6] Goosen WJ, Cooper D, Miller MA, et al. IP-10 Is a Sensitive Biomarker of Antigen Recognition in Whole Blood Stimulation Assays Used for the Diagnosis of Mycobacterium bovis Infection in African Buffaloes (Syncerus caffer). Clin Vaccine Immunol, 2015; 22, 974-8. doi:  10.1128/CVI.00324-15
[7] Harboe M. Antigens of PPD, old tuberculin, and autoclaved Mycobacterium bovis BCG studied by crossed immunoelectrophoresis. Am Rev Respir Dis, 1981; 124, 80-7. http://www.ncbi.nlm.nih.gov/pubmed/7020505
[8] Liebeschuetz S, Bamber S, Ewer K, et al. Diagnosis of tuberculosis in South African children with a T-cell-based assay:a prospective cohort study. Lancet, 2004; 364, 2196-203. doi:  10.1016/S0140-6736(04)17592-2
[9] Bianchi L, Galli L, Moriondo M, et al. Interferon-gamma release assay improves the diagnosis of tuberculosis in children. Pediatr Infect Dis J, 2009; 28, 510-4. doi:  10.1097/INF.0b013e31819abf6b
[10] Andersen P, Munk ME, Pollock JM, et al. Specific immune-based diagnosis of tuberculosis. Lancet, 2000; 356, 1099-104. doi:  10.1016/S0140-6736(00)02742-2
[11] Suzukawa M, Akashi S, Nagai H, et al. Combined Analysis of IFN-γ, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection. PLoS One, 2016; 11, e152483. http://www.ncbi.nlm.nih.gov/pubmed/27035669
[12] Anderson BL, Welch RJ, Litwin CM. Assessment of three commercially available serologic assays for detection of antibodies to Mycobacterium tuberculosis and identification of active tuberculosis. Clin Vaccine Immunol, 2008; 15, 1644-9. doi:  10.1128/CVI.00271-08
[13] Sardella IG, Singh M, Kumpfer S, et al. Evaluation of Lionex TB kits and mycobacterial antigens for IgG and IgA detection in cerebrospinal fluid from tuberculosis meningitis patients. Mem Inst Oswaldo Cruz, 2010; 105, 722-8. doi:  10.1590/S0074-02762010000500022
[14] Deng J, Bi L, Zhou L, et al. Mycobacterium Tuberculosis Proteome Microarray for Global Studies of Protein Function and Immunogenicity. Cell Rep, 2014; 9, 2317-29. doi:  10.1016/j.celrep.2014.11.023
[15] Chan J, Mehta S, Bharrhan S, et al. The role of B cells and humoral immunity in Mycobacterium tuberculosis infection. Semin Immunol, 2014; 26, 588-600. doi:  10.1016/j.smim.2014.10.005
[16] Chen T, Blanc C, Eder AZ, et al. Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction. J Infect Dis, 2016; 214, 300-10. doi:  10.1093/infdis/jiw141
[17] Phuah J, Wong EA, Gideon HP, et al. Effects of B Cell Depletion on Early Mycobacterium tuberculosis Infection in Cynomolgus Macaques. Infect Immun, 2016; 84, 1301-11. doi:  10.1128/IAI.00083-16
[18] Torrado E, Fountain JJ, Robinson RT, et al. Differential and site specific impact of B cells in the protective immune response to Mycobacterium tuberculosis in the mouse. PLoS One, 2013; 8, e61681. doi:  10.1371/journal.pone.0061681
[19] Zhang C, Song X, Zhao Y, et al. Mycobacterium tuberculosis Secreted Proteins As Potential Biomarkers for the Diagnosis of Active Tuberculosis and Latent Tuberculosis Infection. J Clin Lab Anal, 2015; 29, 375-82. doi:  10.1002/jcla.21782
[20] Hur YG, Kim A, Kang YA, et al. Evaluation of antigen-specific immunoglobulin g responses in pulmonary tuberculosis patients and contacts. J Clin Microbiol, 2015; 53, 904-9. doi:  10.1128/JCM.03050-14
[21] Bai XJ, Liang Y, Yang YR, et al. Potential novel markers to discriminate between active and latent tuberculosis infection in Chinese individuals. Comp Immunol Microbiol Infect Dis, 2016; 44, 8-13. doi:  10.1016/j.cimid.2015.11.002
[22] Lu LL, Chung AW, Rosebrock TR, et al. A Functional Role for Antibodies in Tuberculosis. Cell, 2016; 167, 433-43. doi:  10.1016/j.cell.2016.08.072
[23] Hu Y, Movahedzadeh F, Stoker NG, et al. Deletion of the Mycobacterium tuberculosis alpha-crystallin-like hspX gene causes increased bacterial growth in vivo. Infect Immun, 2006; 74, 861-8. doi:  10.1128/IAI.74.2.861-868.2006
[24] Mushtaq K, Sheikh JA, Amir M, et al. Rv2031c of Mycobacterium tuberculosis:a master regulator of Rv2028-Rv2031 (HspX) operon. Front Microbiol, 2015; 6, 351. http://europepmc.org/articles/PMC4410610/
[25] Williams KJ, Jenkins VA, Barton GR, et al. Deciphering the metabolic response of Mycobacterium tuberculosis to nitrogen stress. Mol Microbiol, 2015; 97, 1142-57. doi:  10.1111/mmi.2015.97.issue-6
[26] Cloete R, Oppon E, Murungi E, et al. Resistance related metabolic pathways for drug target identification in Mycobacterium tuberculosis. Bmc Bioinformatics, 2016; 17, 75. doi:  10.1186/s12859-016-0898-8
[27] He XY, Li J, Hao J, et al. Assessment of five antigens from Mycobacterium tuberculosis for serodiagnosis of tuberculosis. Clin Vaccine Immunol, 2011; 18, 565-70. doi:  10.1128/CVI.00507-10
[28] Zhu C, Yang H, Geng Q, et al. Association of oxidative stress biomarkers with gestational diabetes mellitus in pregnant women:a case-control study. PLoS One, 2015; 10, e0126490. doi:  10.1371/journal.pone.0126490
[29] Dessau RB, Ejlertsen T, Hilden J, et al. Simultaneous use of serum IgG and IgM for risk scoring of suspected early Lyme borreliosis:graphical and bivariate analyses. APMIS, 2010; 118, 313-23. doi:  10.1111/apm.2010.118.issue-4